ANTICYTOKINE TREATMENT PREVENTS THE INCREASE IN THE ACTIVITY OF ATP-UBIQUITIN- AND CA2+-DEPENDENT PROTEOLYTIC SYSTEMS IN THE MUSCLE OF TUMOUR-BEARING RATS
- 1 July 2002
- Vol. 19 (1) , 1-5
- https://doi.org/10.1006/cyto.2002.1036
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Loss of skeletal muscle in cancer: biochemical mechanismsFrontiers in Bioscience-Landmark, 2001
- Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout miceMolecular and Cellular Endocrinology, 1998
- Anti-TNF Treatment Reverts Increased Muscle Ubiquitin Gene Expression in Tumour-Bearing RatsBiochemical and Biophysical Research Communications, 1996
- Mechanisms of Inhibition of IL-6-Mediated Immunoglobulin Secretion by Dexamethasone and Suramin in Human Lymphoid and Myeloma Cell Lines1Leukemia & Lymphoma, 1996
- Muscle wasting associated with cancer cachexia is linked to an important activation of the atp‐dependent ubiquitin‐mediated proteolysisInternational Journal of Cancer, 1995
- Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.Journal of Clinical Investigation, 1993
- Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: A pilot studyCancer Immunology, Immunotherapy, 1993
- Review: Abnormal Substrate Metabolism and Nutritional Strategies in Cancer ManagementJournal of Parenteral and Enteral Nutrition, 1991
- Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexiaEuropean Journal of Cancer and Clinical Oncology, 1991
- THE IMMEDIATE CAUSES OF DEATH IN CANCERThe Lancet Healthy Longevity, 1932